These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 3752722)

  • 21. [Bronchodilators in COPD--monotherapy or combined? (The annual ERS congress--Stockholm, Sept. 1996). European Respiratory Society].
    Ulmeanu R; Mihălţan F
    Pneumoftiziologia; 1997; 46(2):145-6. PubMed ID: 9634275
    [No Abstract]   [Full Text] [Related]  

  • 22. [A strategy of drug treatment of obstructive respiratory tract diseases].
    Slapke J; Adolph J
    Z Arztl Fortbild (Jena); 1989; 83(17):857-9. PubMed ID: 2686213
    [No Abstract]   [Full Text] [Related]  

  • 23. [Enprofylline--a new therapeutic possibility in asthma and other obstructive lung diseases].
    Persson CG
    Lakartidningen; 1985 Apr; 82(16):1474-80. PubMed ID: 3999868
    [No Abstract]   [Full Text] [Related]  

  • 24. Bronchodilators in chronic obstructive pulmonary disease.
    Oyalowo MT
    J Pract Nurs; 1996 Mar; 46(1):39-46; quiz47-8. PubMed ID: 8715479
    [No Abstract]   [Full Text] [Related]  

  • 25. Inhaled corticosteroids in COPD: the EUROSCOP study in perspective.
    Yernault JC
    Eur Respir J; 1992 Nov; 5(10):1169-70. PubMed ID: 1486959
    [No Abstract]   [Full Text] [Related]  

  • 26. [Expectorants, antitussive agents, bronchospasmolytic agents. Therapy of obstructive respiratory tract diseases].
    Haen E
    Med Monatsschr Pharm; 1989 Nov; 12(11):344-55. PubMed ID: 2685526
    [No Abstract]   [Full Text] [Related]  

  • 27. [Function analytic control of therapy of obstructive respiratory tract disease].
    Schött D; Micklefield GH; Ulmer WT
    Verh Dtsch Ges Inn Med; 1990; 96():742-5. PubMed ID: 2092516
    [No Abstract]   [Full Text] [Related]  

  • 28. [Acetylcysteine (Fabrol, Mucomyst) in chronic obstructive lung disease/bronchitis].
    Heinig JH; Jørgensen PH
    Ugeskr Laeger; 1984 Apr; 146(16):1229-32. PubMed ID: 6730053
    [No Abstract]   [Full Text] [Related]  

  • 29. [Evaluation of ventilation changes in patients with obstructive bronchopneumopathy induced by bronchodilator drugs].
    De Benedetto F; Cervone M; De Blasio E; D'Ilario F; Fuciarelli R; Luciano A; Sborgia M
    Clin Ter; 1984 Jun; 109(6):509-17. PubMed ID: 6236941
    [No Abstract]   [Full Text] [Related]  

  • 30. [Use of bronchodilators in the therapy of obstructive respiratory diseases].
    Fortschr Med; 1983 Mar; 101(10):435-6. PubMed ID: 6840647
    [No Abstract]   [Full Text] [Related]  

  • 31. Bronchodilators and chronic obstructive pulmonary disease.
    Singh A
    N Z Med J; 1997 Aug; 110(1049):300. PubMed ID: 9293287
    [No Abstract]   [Full Text] [Related]  

  • 32. The use of bronchodilators in stable chronic obstructive pulmonary disease.
    Cazzola M; Spina D; Matera MG
    Pulm Pharmacol Ther; 1997 Jun; 10(3):129-44. PubMed ID: 9514624
    [No Abstract]   [Full Text] [Related]  

  • 33. Airflow limitation--reversible or irreversible.
    Lancet; 1988 Jan 2-9; 1(8575-6):26-7. PubMed ID: 2891892
    [No Abstract]   [Full Text] [Related]  

  • 34. [Bronchodilators: theophylline derivatives].
    Neijens HJ
    Ned Tijdschr Geneeskd; 1986 Nov; 130(46):2068-71. PubMed ID: 3796739
    [No Abstract]   [Full Text] [Related]  

  • 35. [Fenspiride-a new alternative on the therapy of obstructive lung disease].
    Mihălţan F
    Pneumologia; 2003; 52(2):123-5. PubMed ID: 14702716
    [No Abstract]   [Full Text] [Related]  

  • 36. [Treatment of stable chronic obstructive lung disease with inhaled corticosteroid].
    Vestbo J; Lange P
    Ugeskr Laeger; 2000 Jan; 162(4):520-3. PubMed ID: 10697457
    [No Abstract]   [Full Text] [Related]  

  • 37. [New therapeutic possibility in obstructive pulmonary diseases].
    Protivinsky R
    Ther Ggw; 1975 Feb; 114(2):216-7, 220-2, 224-5. PubMed ID: 1118817
    [No Abstract]   [Full Text] [Related]  

  • 38. [Evaluation of drugs for the treatment of chronic obstructive lung diseases--analysis of bronchospasmolytics/antiasthmatics of the Red List 1984].
    Overbeck J; Fabel H
    Prax Klin Pneumol; 1985 Dec; 39(12):957-61. PubMed ID: 4095075
    [No Abstract]   [Full Text] [Related]  

  • 39. Interaction between drugs and lung immune defences in COPD: local evaluation with bronchoalveolar lavage.
    Lusuardi M; Capelli A; Donner CF
    Monaldi Arch Chest Dis; 1993 Oct; 48(5):411-4. PubMed ID: 8312891
    [No Abstract]   [Full Text] [Related]  

  • 40. [Tests of reversibility of bronchial obstruction].
    Meslier N; Racineux JL; Grandordy B
    Rev Mal Respir; 1986; 3(6):355-60. PubMed ID: 3575855
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.